Jian Sun

Corporate Officer/Principal en Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. .

62 años

Health Technology

Perfil

Jian Sun is currently the General Manager at Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.
Prior to this, he was the President at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Cargos activos de Jian Sun

Empresas	Cargo	Inicio
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.	Corporate Officer/Principal	19/08/2011

Todos los cargos activos de Jian Sun

Antiguos cargos conocidos de Jian Sun.

Empresas	Cargo	Fin
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu.	Presidente	-

Ver el detalle de la experiencia de Jian Sun.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jian Sun.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu.	Health Technology
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.